M. N. ÖZTANIR Et Al. , "Secukinumab Ameliorates Oxidative Damage Induced by Cerebral Ischemia-Reperfusion in Rats," TURKISH NEUROSURGERY , vol.32, no.5, pp.732-739, 2022
ÖZTANIR, M. N. Et Al. 2022. Secukinumab Ameliorates Oxidative Damage Induced by Cerebral Ischemia-Reperfusion in Rats. TURKISH NEUROSURGERY , vol.32, no.5 , 732-739.
ÖZTANIR, M. N., Dogan, M. F., BAŞAK TÜRKMEN, N., TAŞLIDERE, A., Sahin, Y., & ÇİFTÇİ, O., (2022). Secukinumab Ameliorates Oxidative Damage Induced by Cerebral Ischemia-Reperfusion in Rats. TURKISH NEUROSURGERY , vol.32, no.5, 732-739.
ÖZTANIR, MUSTAFA Et Al. "Secukinumab Ameliorates Oxidative Damage Induced by Cerebral Ischemia-Reperfusion in Rats," TURKISH NEUROSURGERY , vol.32, no.5, 732-739, 2022
ÖZTANIR, MUSTAFA N. Et Al. "Secukinumab Ameliorates Oxidative Damage Induced by Cerebral Ischemia-Reperfusion in Rats." TURKISH NEUROSURGERY , vol.32, no.5, pp.732-739, 2022
ÖZTANIR, M. N. Et Al. (2022) . "Secukinumab Ameliorates Oxidative Damage Induced by Cerebral Ischemia-Reperfusion in Rats." TURKISH NEUROSURGERY , vol.32, no.5, pp.732-739.
@article{article, author={MUSTAFA NAMIK ÖZTANIR Et Al. }, title={Secukinumab Ameliorates Oxidative Damage Induced by Cerebral Ischemia-Reperfusion in Rats}, journal={TURKISH NEUROSURGERY}, year=2022, pages={732-739} }